Aimei Health Technology Co., Ltd carries a market capitalization of 165.29M, placing it among publicly traded companies globally.
| Market Cap | 165.29M |
| Enterprise Value | N/A |
Aimei Health Technology Co., Ltd currently has 3.17M shares outstanding.
| Shares Outstanding | 3.17M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Aimei Health Technology Co., Ltd trades at a trailing price-to-earnings ratio of 136.71.
| PE Ratio | 136.71 |
| PS Ratio | N/A |
| PB Ratio | 15.56 |
| P/TBV Ratio | 15.56 |
| P/FCF Ratio | -302.73 |
| P/OCF Ratio | -302.73 |
Aimei Health Technology Co., Ltd maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
| Return on Equity (ROE) | 3.73 |
| Return on Assets (ROA) | 3.29 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Aimei Health Technology Co., Ltd's stock has gained approximately 143.24324% over the past 52 weeks. The 50-day moving average sits at 39.07, while the 200-day moving average is 32.69.
| Beta (5Y) | N/A |
| 52-Week Price Change | 143.24324% |
| 50-Day Moving Average | 39.07 |
| 200-Day Moving Average | 32.69 |
| Average Volume (20 Days) | N/A |
EBITDA reached -484,329.00, while operating income came in at -484,329.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -484,329.00 |
| Pretax Income | 920,546.00 |
| Net Income | 920,546.00 |
| EBITDA | -484,329.00 |
| EBIT | -484,329.00 |
| Earnings Per Share (EPS) | 0.18 |
Total book value stands at 8.09M, with working capital of -3.50M providing operational flexibility.
| Cash & Cash Equivalents | 18,516.00 |
| Total Debt | N/A |
| Net Debt | 2.07M |
| Equity (Book Value) | 8.09M |
| Book Value Per Share | 1.57 |
| Working Capital | -3.50M |
Aimei Health Technology Co., Ltd produced -415,704.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -415,704.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -415,704.00 |
| FCF Per Share | -0.08 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 25.66 |
| FCF Yield | -0.33 |
Aimei Health Technology Co., Ltd posts an Altman Z-Score of 16.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.99 |